PTPRC and neoplasm: Despite the decrease of CD45+ cells, which may contain both anti-tumor and pro-tumor immune cells, in the cold-exposed tumor, future works should be broadened to include single-cell multi-omic analysis of various organs and tissues to decipher the immune landscape of CITS and its potential impact on anti-tumor immunity.